Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Nov 12:32:11-14.
doi: 10.1016/j.jdcr.2022.11.009. eCollection 2023 Feb.

Efficacy of textile photodynamic therapy for mycosis fungoides

Elise Toulemonde  1 , Marion Douxami  1 , Sarah Faiz  1   2 , Romain Dubois  3 , Marie Verhasselt-Crinquette  3 , Olivier Carpentier  1   4 , Henry Abi Rached  1 , Laurent Mortier  5
Affiliations
Case Reports

Efficacy of textile photodynamic therapy for mycosis fungoides

Elise Toulemonde et al. JAAD Case Rep. .
No abstract available

Keywords: CTCL; MF, Mycosis fungoides; cPDT, Conventional photodynamic therapy; conventional photodynamic therapy; cutaneous T-cell lymphoma; dermaroller; methyl aminolevulinate; microneedling; mycosis fungoides; tPDT, Textile photodynamic therapy; textile photodynamic therapy.

PubMed Disclaimer

Conflict of interest statement

None disclosed.

Figures

Fig 1
Fig 1
Skin biopsy sample of patient 1 confirming the diagnosis of follicular mycosis fungoides. A, dense pilotropic lymphoid infiltrates and (B) mucin deposits. C, Positivity for CD3 staining. D, Negativity for CD8 staining.
Fig 2
Fig 2
Mycosis fungoides in patient 1 at (A) baseline, with pink plaque on the cheek with follicular accentuation, and (B) after the fifth treatment.
Fig 3
Fig 3
Skin biopsy sample of patient 2 confirming the diagnosis of follicular mycosis fungoides. A, Dense pilotropic infiltrates without deposition of mucin with (B) CD3 expression, (C) partial loss of CD7, and (D) comedones.
Fig 4
Fig 4
Mycosis fungoides in patient 2 at (A) baseline and (B) 3 months after the third treatment.
See this image and copyright information in PMC

References

    1. Kalka K., Merk H., Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol. 2000;42(3):389–413. doi: 10.1016/s0190-9622(00)90209-3. J Am Acad Dermatol. 2000;43(4):609. J Am Acad Dermatol. 2001;44(1):150. - DOI - PubMed
    1. Seyed Jafari S.M., Cazzaniga S., Hunger R.E. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis. G Ital Dermatol Venereol. 2018;153(6):827–832. doi: 10.23736/S0392-0488.18.05977-1. - DOI - PubMed
    1. Quéreux G., Brocard A., Saint-Jean M., et al. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature. J Am Acad Dermatol. 2013;69(6):890–897. doi: 10.1016/j.jaad.2013.07.047. - DOI - PubMed
    1. Kim S.T., Kang D.Y., Kang J.S., Baek J.W., Jeon Y.S., Suh K.S. Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. Acta Derm Venereol. 2012;92(3):264–268. doi: 10.2340/00015555-1261. - DOI - PubMed
    1. Fernández-Guarino M., Harto A., Pérez-García B., Montull C., De Las Heras E., Jaén P. Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients. Article in Spanish. Actas Dermosifiliogr. 2010;101(9):785–791. - PubMed

Publication types

LinkOut - more resources